BamSEC and AlphaSense Join Forces
Learn More

Avidity Biosciences Inc. – Material Contracts

Formerly NASDAQ: RNAM
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 4 pages [Name] via Email Re: Accelerated Payments and Clawback Dear [Name]
12/34/56
EX-10.2
from 10-Q 46 pages Material contract
12/34/56
EX-10.1
from 8-K 3 pages In Witness Whereof, I Hereby Certify That This Amendment Was Duly Adopted by the Board of Directors of Avidity Biosciences, Inc. on September 9, 2025. Avidity Biosciences, Inc. By: /S/ John B. Moriarty, Jr., J.D. John B. Moriarty, Jr., J.D. Chief Legal Officer and Corporate Secretary Date: September 9, 2025
12/34/56
EX-10.2
from 10-Q 11 pages Material contract
12/34/56
EX-10.1
from 10-Q 4 pages Material contract
12/34/56
EX-10.20
from 10-K 27 pages Material contract
12/34/56
EX-10.15
from 10-K 14 pages Material contract
12/34/56
EX-10.14
from 10-K 14 pages Material contract
12/34/56
EX-10.13
from 10-K 14 pages Material contract
12/34/56
EX-10.12
from 10-K 14 pages Material contract
12/34/56
EX-10.6
from 10-Q 14 pages Material contract
12/34/56
EX-10.5
from 10-Q 13 pages Material contract
12/34/56
EX-10.4
from 10-Q 14 pages Material contract
12/34/56
EX-10.3
from 10-Q 14 pages Material contract
12/34/56
EX-10.2
from 10-Q 14 pages Material contract
12/34/56
EX-10.2
from 10-Q 39 pages Material contract
12/34/56
EX-10.1
from 8-K 3 pages In Witness Whereof, I Hereby Certify That This Amendment Was Duly Adopted by the Board of Directors of Avidity Biosciences, Inc. on June 10, 2024. Avidity Biosciences, Inc. By: /S/ John W. Wallen III, PH.D., J.D. John W. Wallen III, PH.D., J.D. General Counsel Date: June 10, 2024
12/34/56
EX-10.1
from 10-Q 3 pages Avidity Biosciences, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 8-K 38 pages Avidity Biosciences, Inc. Securities Purchase Agreement
12/34/56
EX-10.14
from 10-K 28 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Such Omitted Information Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Securities Purchase Agreement
12/34/56